Enoch120 Posted - 17 hours ago

$UBX Sounds like positive progress for UBX1325!

DonCorleone77 Posted - 17 hours ago

$UBX Unity Biotechnology announces extension of Phase 2b ASPIRE study of UBX1325 UNITY Biotechnology announced that the ongoing Phase 2b ASPIRE study of UBX1325 has been extended from 24 to 36 weeks to assess potentially greater durability compared to aflibercept. In addition, the study is being upsized from 40 to 50 patients to increase the statistical power. The ASPIRE study is designed to evaluate the safety, efficacy, and long-term durability of UBX1325 as a monotherapy compared head-to-head to aflibercept in patients with diabetic macular edema, DME. "We previously demonstrated significant improvement in vision with extended durability in patients treated with UBX1325 in the BEHOLD proof-of-concept study and look forward to extending those findings in the current ASPIRE study," said Anirvan Ghosh, Ph.D., chief executive officer of UNITY. "As the only treatment candidate in clinical development for DME that targets senescent cells, UBX1325 leverages a novel mechanism of action that could provide sustained improvements in visual acuity and lessen the treatment burden compared to current standard of care. We see UBX1325 as an emerging, potentially paradigm-shifting therapeutic approach in DME." As a result of extending the study, UNITY expects to disclose topline results from the ASPIRE study in two data readouts: 24-week primary endpoint data in the first quarter of 2025, and 36-week long-term extension data in the second quarter of 2025. The Company continues to believe that current cash, cash equivalents and marketable securities are sufficient to fund operations into the third quarter of 2025.

Stock_Titan Posted - 18 hours ago

$UBX UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME https://www.stocktitan.net/news/UBX/unity-biotechnology-announces-extension-of-phase-2b-aspire-clinical-yghfmcj38voq.html

ThomasIchim Posted - 3 days ago

@DoeNumber2 @rosiebelle why are you confrontational? if you are all shareholders then lets work together for $TSOI I didnt block anyone market must be terrible...maybe im missing something but why would a company with 40 million in bank have a market cap of 24 million? im thinking $ubx ...i know the science is solid and they are in the clinic this is a stock forum so lets talk about stocks instead of calling each other names lol...

ThomasIchim Posted - 3 days ago

$UBX What a cool company !! they had 43 million in cash but market cap of 24 million ....sounds to me like a great buy...please give your thoughts https://ir.unitybiotechnology.com/static-files/d1b07c4d-349d-418b-ae74-8631cfec4f6d of course $TSOI is awesome but you all know I am biased...for obvious reasons

ThomasIchim Posted - 3 days ago

$UBX one thing great came out of my discussions on the $TSOI board....I learned about this super cool company that has a small molecule inhibitor of senescent cells called Unity Biotechnology !!

ThomasIchim Posted - 3 days ago

$UBX is such an exciting company...just learned about this exciting way to potentially cure #diabetic #blindness https://pubmed.ncbi.nlm.nih.gov/38321220/

OckhamsRazor44 Posted - 5 days ago

$BIIB $EDIT $CRSP $UBX $LEAS

StockRoomBully Posted - 5 days ago

$LEAS that's why everything has been so discreet $Rwod shareholders approved $CRSP $EDIT $BIIB $UBX We have license and Patent https://www.prnewswire.com/news-releases/kogenix-licenses-gene-therapy-for-prevention-of-age-related-dementia-and-alzheimers-300546433.html "PF4 actually causes the immune system to look younger, it’s decreasing all of these active pro-aging immune factors, leading to a brain with less inflammation, more plasticity and eventually more cognition,” Villeda said. “We’re taking 22-month-old mice, equivalent to a human in their 70s, and PF4 is bringing them back to function close to their late 30s, early 40." They committed to releasing their findings at the same time to make the case for PF4 from three different angles. “When we realized we had independently and serendipitously found the same thing, our jaws dropped,” Dubal said. “The fact that three separate interventions converged on platelet factors truly highlights the validity and reproducibility of this biology. The time has come to pursue platelet factors in brain health and cognitive enhancement.” https://scitechdaily.com/unlocking-the-secrets-of-youth-scientists-identify-blood-factor-that-can-turn-back-time-in-the-aging-brain/

Thestocktraderhubzee Posted - 6 days ago

WATCHLIST APR 17 2024 $UBX HC Wainwright & Co. Maintains Buy on Unity Biotechnology, Lowers Price Target to $8 $MRNS RBC Capital Downgrades Marinus Pharma to Sector Perform, Lowers Price Target to $3 $CGEM HC Wainwright & Co. Maintains Buy on Cullinan Oncology, Lowers Price Target to $29 $GPN Barclays Maintains Overweight on Global Payments, Lowers Price Target to $160 $AMZN Roth MKM Maintains Buy on Amazon.com, Maintains $205 Price Target

Fullratio Posted - 1 week ago

$UBX revenue has plunged by 100% YoY: https://fullratio.com/stocks/nasdaq-ubx/unity-biotechnology

Thestocktraderhubzee Posted - 1 week ago

$UBX HC Wainwright & Co. Maintains Buy on Unity Biotechnology, Lowers Price Target to $8

DonCorleone77 Posted - 1 week ago

$UBX Unity Biotechnology reports Q4 EPS (28c), consensus (72c) "On the heels of positive BEHOLD data, our team is currently single-mindedly focused on the enrollment and execution of our Phase 2b ASPIRE study in diabetic macular edema, comparing UBX1325 against aflibercept" said Anirvan Ghosh, Ph.D., chief executive officer of UNITY. "I am pleased to note that thanks to the team's financial and operational discipline we have been able to upsize our ASPIRE study to 50 patients to maximize the ability to differentiate UBX1325 from the current standard of care."

Stock_Titan Posted - 1 week ago

$UBX UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates https://www.stocktitan.net/news/UBX/unity-biotechnology-inc-reports-fourth-quarter-and-full-year-2023-097dj8pda2v6.html

Coinbit Posted - 3 weeks ago

$UBX 6.25 by the end of May

Zweiaugen Posted - 03/28/24

$UBX I only think forward from now on

Tomppa Posted - 1 month ago

$UBX is time soon ?

ChiefOG Posted - 1 month ago

$UBX 👌

Joeschmo420 Posted - 1 month ago

$UBX eventually …

CannonBullRun Posted - 1 month ago

$UBX nice to see Peter Thiel’s Founders Fund is invested here.

SocioCobb Posted - 1 month ago

$UBX 👀 on for reversal here...

JayDuke Posted - 02/28/24

$UBX what happened why did it drop 20 cents?

TradewithSam_G Posted - 02/26/24

$UBX only selling at $100++ so keep the gains coming

TickerDD_com Posted - 02/26/24

From 2/16/2024, looking back across 22 Month-Ends for UBX, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had More Positives (95%) $UBX #UBX #UBXStock #TickerDD #UBXPrice https://www.youtube.com/watch?v=BEpH3ic57Q0

SocioCobb Posted - 2 months ago

$UBX Looks like a cup and handle pattern developing with 2 bucks being resistance for now. Going to wait for this to close above for a swing...

Stocks4thought Posted - 2 months ago

$UBX Consistent.

JayDuke Posted - 2 months ago

$UBX what are peoples thoughts about UBX? is this a good company with lots of upside or is it just a long shot?

Stocks4thought Posted - 2 months ago

$UBX And the winner is?

Stocks4thought Posted - 2 months ago

$UBX Pigs in a blanket$

AAUS1 Posted - 2 months ago

$UBX Selling in loss here …